KMG Fiduciary Partners’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.57M | Buy |
9,856
+2,758
| +39% | +$944K | 0.33% | 68 |
|
|
2026
Q1 | $2.5M | Sell |
7,098
-114
| -2% | -$40.6K | 0.18% | 121 |
|
|
2025
Q4 | $2.36M | Buy |
7,212
+419
| +6% | +$133K | 0.17% | 119 |
|
|
2025
Q3 | $1.92M | Sell |
6,793
-226
| -3% | -$65.5K | 0.13% | 143 |
|
|
2025
Q2 | $1.96M | Sell |
7,019
-138
| -2% | -$39.1K | 0.15% | 133 |
|
|
2025
Q1 | $2.23M | Buy |
7,157
+93
| +1% | +$27.5K | 0.19% | 121 |
|
|
2024
Q4 | $1.84M | Sell |
7,064
-374
| -5% | -$111K | 0.15% | 130 |
|
|
2024
Q3 | $2.4M | Buy |
7,438
+9
| +0.1% | +$2.94K | 0.21% | 107 |
|
|
2024
Q2 | $2.32M | Sell |
7,429
-25
| -0.3% | -$7.34K | 0.23% | 92 |
|
|
2024
Q1 | $2.12M | Sell |
7,454
-8,078
| -52% | -$2.36M | 0.22% | 97 |
|
|
2023
Q4 | $4.47M | Buy |
15,532
+297
| +2% | +$80.9K | 0.52% | 49 |
|
|
2023
Q3 | $4.09M | Buy |
15,235
+557
| +4% | +$139K | 0.54% | 46 |
|
|
2023
Q2 | $3.26M | Buy |
14,678
+8,362
| +132% | +$1.94M | 0.42% | 64 |
|
|
2023
Q1 | $1.53M | Sell |
6,316
-517
| -8% | -$127K | 0.22% | 112 |
|
|
2022
Q4 | $1.79M | Sell |
6,833
-1,604
| -19% | -$430K | 0.29% | 87 |
|
|
2022
Q3 | $1.9M | Sell |
8,437
-4,882
| -37% | -$1.18M | 0.37% | 74 |
|
|
2022
Q2 | $3.24M | Sell |
13,319
-2,939
| -18% | -$720K | 0.6% | 43 |
|
|
2022
Q1 | $3.93M | Sell |
16,258
-3,479
| -18% | -$799K | 0.63% | 42 |
|
|
2021
Q4 | $4.44M | Buy |
19,737
+710
| +4% | +$150K | 0.69% | 38 |
|
|
2021
Q3 | $4.05M | Buy |
19,027
+2,575
| +16% | +$593K | 0.69% | 39 |
|
|
2021
Q2 | $4.01M | Buy |
16,452
+385
| +2% | +$94.7K | 0.71% | 39 |
|
|
2021
Q1 | $4M | Buy |
16,067
+1,187
| +8% | +$283K | 0.78% | 36 |
|
|
2020
Q4 | $3.39M | Buy |
14,880
+1,142
| +8% | +$263K | 0.71% | 37 |
|
|
2020
Q3 | $3.49M | Buy |
13,738
+127
| +0.9% | +$31.5K | 0.87% | 34 |
|
|
2020
Q2 | $3.21M | Buy |
13,611
+3,305
| +32% | +$754K | 0.89% | 34 |
|
|
2020
Q1 | $2.09M | Buy |
10,306
+1,423
| +16% | +$311K | 0.68% | 44 |
|
|
2019
Q4 | $2.14M | Buy |
8,883
+3,541
| +66% | +$781K | 0.65% | 40 |
|
|
2019
Q3 | $1.03M | Sell |
5,342
-640
| -11% | -$123K | 0.35% | 55 |
|
|
2019
Q2 | $1.1M | Buy |
5,982
+430
| +8% | +$77K | 0.4% | 49 |
|
|
2019
Q1 | $1.05M | Buy |
5,552
+90
| +2% | +$17.2K | 0.4% | 51 |
|
|
2018
Q4 | $1.06M | Buy |
+5,462
| New | +$1.07M | 0.48% | 40 |
|
Other funds holding AMGN
KMG Fiduciary Partners's AMGN Position: Q2 2026 in Review
KMG Fiduciary Partners increased its Amgen (AMGN) stake by 39% in Q2 2026, buying an estimated $944K and bringing the position to 9,856 shares worth $3.57M. The position accounts for 0.33% of the portfolio, ranked #68.
KMG Fiduciary Partners first reported a position in AMGN in Q4 2018 and has held it in 31 quarters since. The position peaked at $4.47M in Q4 2023. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.
- KMG Fiduciary Partners held 9,856 shares of Amgen worth $3.57M as of Q2 2026.
- KMG Fiduciary Partners bought 2,758 Amgen shares in Q2 2026, an estimated $944K.
- Amgen made up 0.33% of KMG Fiduciary Partners's portfolio in Q2 2026, its #68 holding.
- KMG Fiduciary Partners first reported a position in Amgen in Q4 2018 and has held it in 31 quarters since.
- KMG Fiduciary Partners's Amgen position peaked at $4.47M in Q4 2023.
- 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.
Based on KMG Fiduciary Partners's 13F filing for Q2 2026, filed 9 Jul 2026.